I M Monteiro1, A J Bedone, C L Pinto, S R Brandalise. 1. Departamento de Tocoginecologia, Faculdade de Cências Médicas-Centro de Atenção Integral à Saúde da Mulher da UNICAMP, Campinas, SP.
Abstract
BACKGROUND: The treatment of the acute lymphocytic leukaemia can determine impaired growth. SUBJECTS AND METHOD: All the patients had length measurements at the time of the beginning of the treatment and, at least, one year after the end of it. CONCLUSIONS: There was impaired growth after the treatment according to the dose regimens (18 or 24 Grays). No relation was observed related to the age at the diagnosis.
BACKGROUND: The treatment of the acute lymphocytic leukaemia can determine impaired growth. SUBJECTS AND METHOD: All the patients had length measurements at the time of the beginning of the treatment and, at least, one year after the end of it. CONCLUSIONS: There was impaired growth after the treatment according to the dose regimens (18 or 24 Grays). No relation was observed related to the age at the diagnosis.
Authors: Pankaj Kumar; Amita Trehan; A K Bhalla; R K Marwaha; Deepak Bansal Journal: Indian J Hematol Blood Transfus Date: 2015-02-17 Impact factor: 0.900